How to help

How to help with the case

This isn't only about money: there's a way to help for everyone. Find yours.

To revisit the case, you'll find it in The science and the Timeline.

By profile

Depending on who you are.

Pick the path that fits you. If none fits, write to us and we'll figure it out.

Clinical review

Medical professional or researcher

  • Second read of the molecular profile (FGFR1 ×13, CCND1 ×20, ~80% neuroendocrine differentiation).
  • Access to N-of-1, FGFR, neuroendocrine or precision oncology trials.
  • Contacts with oncologists specialized in BC-NED or 11q13 amplification.
  • Treatment line proposals targeted at the active drivers.
Contribute a clinical review

We reply by email. No commitment.

Reach

You have an audience, community or media outlet

The case needs to reach the right people: oncology, research or patients. Share the site or any social post. If you cover health, biotech or science, write to us and we'll send a press kit with verifiable data.

Request the press kit

We'll send you the press kit by email.

Peer support

You are a patient or supporting someone in a similar situation

You don't have to contribute anything: if it helps to know this case exists and is documented in the open, that already serves its purpose. And if you'd like to share yours or write to Miriam, you can do it by email or DM. Miriam or someone on the team tries to reply when they can.

Write to Miriam

Miriam or someone on the team will try to reply.

What moves the needle most

Fund the research behind the case

Every euro funds research applied to a single case: deep sequencing, molecular rebiopsy, transcriptomics, international second opinions and the N-of-1 trial when biology justifies it. Open budgets. Downloadable expense report.

Fund the research

Secure payment. Receipt available. 100% to Miriam's case.

Thank you

Thanks to those who make it possible

Links

If you don't know where to start, share the site. Getting the case in front of the right people —oncology, research or patients— is often the difference between finding a therapeutic target and not finding one.

— Miriam González's team · Beyond the Protocol